{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:10:08Z","timestamp":1749877808372,"version":"3.41.0"},"reference-count":26,"publisher":"The Japanese Society of Interventional Radiology","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,13]]},"DOI":"10.22575\/interventionalradiology.2024-0031","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T22:07:11Z","timestamp":1749766031000},"page":"e2024-0031-e2024-0031","source":"Crossref","is-referenced-by-count":0,"title":["Complete Protocol Administration Reduces Local Recurrence and Residual Tumor in Superselective Intra-arterial Cisplatin Infusion and Concomitant Radiotherapy for Maxillary Sinus Cancer"],"prefix":"10.22575","volume":"10","author":[{"given":"Hirokazu","family":"Ashida","sequence":"first","affiliation":[{"name":"Department of Radiology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kisaki","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenkichi","family":"Michimoto","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideomi","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Kessoku","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, The Jikei University School of Medicine Kashiwa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Nishiya","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, National Cancer Center Hospital East"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Ojiri","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"9863","reference":[{"key":"1","unstructured":"1. Committee J. SfHaNCCR. Report of head and neck cancer registry of Japan clinical statistics of registered patients 2019. http:\/\/www.jshnc.umin.ne.jp\/pdf\/HNCreport_2019.pdf (Accessed March 21, 2025)"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Koyama S, Ehara H, Donishi R, et al. Photoimmunotherapy with surgical navigation and computed tomography guidance for recurrent maxillary sinus carcinoma. Auris Nasus Larynx. 2023; 50: 646-651.","DOI":"10.1016\/j.anl.2022.09.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ebara T, Ando K, Eishima J, et al. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma. Jpn J Radiol. 2019; 37: 494-499.","DOI":"10.1007\/s11604-019-00827-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ono T, Tanaka N, Umeno H, et al. Treatment outcomes of locally advanced squamous cell carcinoma of the ethmoid sinus treated with anterior craniofacial resection or chemoradiotherapy. Case Rep Oncol. 2017; 10: 339-349.","DOI":"10.1159\/000470834"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wang Y, Yang R, Zhao M, et al. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration. World J Surg Oncol. 2020; 18: 90.","DOI":"10.1186\/s12957-020-01862-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ashida H, Igarashi T, Nozawa Y, et al. Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT). Head Face Med. 2021; 17: 34.","DOI":"10.1186\/s13005-021-00285-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Makino T, Tachibana T, Kariya S, et al. Pathological evaluation of radiotherapy and concomitant intraarterial cisplatin for maxillary sinus cancer. Auris Nasus Larynx. 2020; 47: 881-886.","DOI":"10.1016\/j.anl.2020.04.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kang JH, Cho SH, Kim JP, et al. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and\/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis. J Oral Maxillofac Surg. 2012; 70: 1717-1723.","DOI":"10.1016\/j.joms.2011.06.221"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jang NY, Wu HG, Park CI, et al. Definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity. Jpn J Clin Oncol. 2010; 40: 542-548.","DOI":"10.1093\/jjco\/hyq009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Homma A, Sakashita T, Yoshida D, et al. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer. 2013; 109: 2980-2986.","DOI":"10.1038\/bjc.2013.663"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Homma A, Oridate N, Suzuki F, et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer. 2009; 115: 4705-4714.","DOI":"10.1002\/cncr.24515"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shiga K, Yokoyama J, Hashimoto S, et al. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg. 2007; 136: 1003-1009.","DOI":"10.1016\/j.otohns.2006.12.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Robbins KT, Doweck I, Samant S, Vieira F, Kumar P. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope. 2004; 114: 411-417.","DOI":"10.1097\/00005537-200403000-00004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Homma A, Onimaru R, Matsuura K, et al. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): dose-finding phase. Head Neck. 2018; 40: 475-484.","DOI":"10.1002\/hed.25001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Horie S, Oya M, Nangaku M, et al. Guidelines for treatment of renal injury during cancer chemotherapy 2016. Clin Exp Nephrol. 2018; 22: 210-244.","DOI":"10.1007\/s10157-017-1448-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rasch CR, Hauptmann M, Schornagel J, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer. 2010; 116: 2159-2165.","DOI":"10.1002\/cncr.24916"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nishiyama H, Inoue T, Koizumi Y, et al. Chapter 2: indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022. Int J Clin Oncol. 2023; 28: 1298-1314.","DOI":"10.1007\/s10147-023-02377-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Okamoto K, Saito Y, Narumi K, Furugen A, Iseki K, Kobayashi M. Non-steroidal anti-inflammatory drugs are a risk factor for cisplatin-induced nephrotoxicity: a meta-analysis of retrospective studies. Anticancer Res. 2020; 40: 1747-1751.","DOI":"10.21873\/anticanres.14128"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lewis SL, Brody R, Touger-Decker R, Parrott JS, Epstein J. Feeding tube use in patients with head and neck cancer. Head Neck. 2014; 36: 1789-1795.","DOI":"10.1002\/hed.23538"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Baschnagel AM, Yadav S, Marina O, et al. Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy. Head Neck. 2014; 36: 1155-1161.","DOI":"10.1002\/hed.23426"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bossola M, Antocicco M, Pepe G. Tube feeding in patients with head and neck cancer undergoing chemoradiotherapy: a systematic review. JPEN J Parenter Enter Nutr. 2022; 46: 1258-1269.","DOI":"10.1002\/jpen.2360"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Homma A, Mikami M, Matsuura K, et al. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (JCOG1212): results of the efficacy confirmation phase in patients with T4aN0M0. Int J Radiat Oncol Biol Phys. 2024; 118: 1271-1281.","DOI":"10.1016\/j.ijrobp.2023.11.031"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Salvador E, Shityakov S, F\u00f6rster C. Glucocorticoids and endothelial cell barrier function. Cell Tissue Res. 2014; 355: 597-605.","DOI":"10.1007\/s00441-013-1762-z"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Campia U. Vascular effects of cancer treatments. Vasc Med. 2020; 25: 226-234.","DOI":"10.1177\/1358863X20914978"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Liu XC, Zhou PK. Tissue reactions and mechanism in cardiovascular diseases induced by radiation. Int J Mol Sci. 2022; 23: 14786.","DOI":"10.3390\/ijms232314786"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sangal NR, Lee YJ, Brady JS, et al. The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma. Laryngoscope. 2018; 128: 1835-1841.","DOI":"10.1002\/lary.27009"}],"container-title":["Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/interventionalradiology\/10\/0\/10_2024-0031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:29:11Z","timestamp":1749875351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/interventionalradiology\/10\/0\/10_2024-0031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":26,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.22575\/interventionalradiology.2024-0031","relation":{},"ISSN":["2432-0935"],"issn-type":[{"type":"electronic","value":"2432-0935"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"article-number":"2024-0031"}}